Literature DB >> 31040439

Enzalutamide, apalutamide, or darolutamide: are apples or bananas best for patients?

Celestia Higano1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31040439     DOI： 10.1038/s41585-019-0186-2

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  9 in total

Review 1.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

Review 2.  Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis.

Authors:  Yupeng Guan; Haiyun Xiong; Yupeng Feng; Guolong Liao; Tongyu Tong; Jun Pang
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-02-07       Impact factor: 5.554

3.  GSTM2 is a key molecular determinant of resistance to SG-ARIs.

Authors:  Chaohao Li; Jinpeng Liu; Daheng He; Fengyi Mao; Xiongjian Rao; Yue Zhao; Nadia A Lanman; Majid Kazemian; Elia Farah; Jinghui Liu; Chrispus M Ngule; Zhuangzhuang Zhang; Yanquan Zhang; Yifan Kong; Lang Li; Chi Wang; Xiaoqi Liu
Journal:  Oncogene       Date:  2022-08-29       Impact factor: 8.756

4.  Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer.

Authors:  Elisa M Ledet; Michael B Lilly; Guru Sonpavde; Edwin Lin; Roberto H Nussenzveig; Pedro C Barata; Mark Yandell; Rebecca J Nagy; Lesli Kiedrowski; Neeraj Agarwal; Oliver Sartor
Journal:  Oncologist       Date:  2019-11-11

Review 5.  Treatment and trials in non-metastatic castration-resistant prostate cancer.

Authors:  Soum D Lokeshwar; Zachary Klaassen; Fred Saad
Journal:  Nat Rev Urol       Date:  2021-05-17       Impact factor: 14.432

Review 6.  Non-nuclear AR Signaling in Prostate Cancer.

Authors:  Alice Zamagni; Michela Cortesi; Michele Zanoni; Anna Tesei
Journal:  Front Chem       Date:  2019-09-26       Impact factor: 5.221

7.  Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer.

Authors:  Anna R Michmerhuizen; Lynn M Lerner; Connor Ward; Andrea M Pesch; Amanda Zhang; Rachel Schwartz; Kari Wilder-Romans; Joel R Eisner; James M Rae; Lori J Pierce; Corey W Speers
Journal:  Br J Cancer       Date:  2022-05-26       Impact factor: 9.075

8.  Inferences About Drug Safety in Phase III Trials in Oncology: Examples From Advanced Prostate Cancer.

Authors:  Joshua Z Drago; Mithat Gönen; Gita Thanarajasingam; Chana A Sacks; Michael J Morris; Philip W Kantoff; Konrad H Stopsack
Journal:  J Natl Cancer Inst       Date:  2021-05-04       Impact factor: 13.506

9.  Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer.

Authors:  Elisa M Ledet; Michael B Lilly; Guru Sonpavde; Edwin Lin; Roberto H Nussenzveig; Pedro C Barata; Mark Yandell; Rebecca J Nagy; Lesli Kiedrowski; Neeraj Agarwal; Oliver Sartor
Journal:  Oncologist       Date:  2019-11-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.